Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Basic transcription factor 3 pseudogene 15 (BTF3P15) is a pseudogene in humans and not an active protein-coding gene. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional due to mutations or lack of regulatory elements. BTF3P15 is designated as a "pseudogene" of the protein-coding basic transcription factor 3 (BTF3) gene, which plays a key role in the initiation of transcription via association with RNA polymerase II. While some pseudogenes can exert regulatory functions through non-coding RNA products, microRNA interaction, or antisense transcripts, there is currently no evidence that BTF3P15 encodes any functional RNA or protein, nor is it implicated in any physiological, pathological, or pharmacological processes.
None applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Basic transcription factor 3 pseudogene 15 (BTF3P15).